Emily A. Liu
- Molecular Biology top 2%
- Oncology top 1%
- Cancer Research top 5%
- Organic Chemistry top 5%
- Biotechnology top 1%
- Co-authors
- Frank PodlaskiChristine LukacsNader FotouhiChristian KleinZoran FilipovicNorman KongU. KammlottBradford Graves
- Topics
- Chronic Lymphocytic Leukemia Research (3 papers)Lymphoma Diagnosis and Treatment (2 papers)Gastrointestinal Tumor Research and Treatment (1 paper)
- Journals
- ScienceBloodClinical Cancer Research
- Partner nations
- United StatesGermany
In The Last Decade
Emily A. Liu
5 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Molecular Biology 2.9k
- Oncology 2.3k
- Cancer Research 489
- Organic Chemistry 448
- Biotechnology 359
Countries citing papers authored by Emily A. Liu
This map shows the geographic impact of Emily A. Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily A. Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily A. Liu more than expected).
Fields of papers citing papers by Emily A. Liu
This network shows the impact of papers produced by Emily A. Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily A. Liu. The network helps show where Emily A. Liu may publish in the future.
Co-authorship network of co-authors of Emily A. Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Emily A. Liu. A scholar is included among the top collaborators of Emily A. Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily A. Liu. Emily A. Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 126 | |
| 2 | 47 | |
| 3 | 13 | |
| 4 | 14 | |
| 5 | In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2breakdown → | 3722 |
About Emily A. Liu
Emily A. Liu is a scholar working on Genetics, Gastroenterology and Hepatology, having authored 5 papers that have together received 3.9k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (2 papers) and Gastrointestinal Tumor Research and Treatment (1 paper). The work is most often cited by research in Oncology (2.3k citations), Molecular Biology (2.9k citations) and Biotechnology (359 citations). Emily A. Liu has collaborated with scholars based in United States and Germany. Frequent co-authors include Frank Podlaski, Christine Lukacs, Nader Fotouhi, Christian Klein, Zoran Filipovic, Norman Kong, U. Kammlott, Bradford Graves, Daisy Carvajal and Binh Thanh Vu. Their work appears in journals such as Science, Blood and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.